Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-03
DOI
10.1038/s41380-019-0401-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What does plasma CRP tell us about peripheral and central inflammation in depression?
- (2018) Jennifer C. Felger et al. MOLECULAR PSYCHIATRY
- Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia
- (2018) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
- (2018) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
- (2017) Danny Boerrigter et al. Journal of Neuroinflammation
- Investigating the neuroimmunogenic architecture of schizophrenia
- (2017) R Birnbaum et al. MOLECULAR PSYCHIATRY
- The kynurenine pathway in schizophrenia and bipolar disorder
- (2017) Sophie Erhardt et al. NEUROPHARMACOLOGY
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
- (2017) Chai K. Lim et al. Scientific Reports
- Tryptophan Metabolism and White Matter Integrity in Schizophrenia
- (2016) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies
- (2016) Olaoluwa Okusaga et al. PSYCHOSOMATIC MEDICINE
- Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive Decline
- (2016) Danielle Weinberg et al. JAMA Psychiatry
- Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
- (2015) David W. Volk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
- (2015) Tyrone D. Cannon et al. BIOLOGICAL PSYCHIATRY
- Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume
- (2015) S G Fillman et al. MOLECULAR PSYCHIATRY
- Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition
- (2014) Katerina Zavitsanou et al. BRAIN BEHAVIOR AND IMMUNITY
- Reduction of Brain Kynurenic Acid Improves Cognitive Function
- (2014) R. Kozak et al. JOURNAL OF NEUROSCIENCE
- Stress-Induced Increase in Kynurenic Acid as a Potential Biomarker for Patients With Schizophrenia and Distress Intolerance
- (2014) Joshua Chiappelli et al. JAMA Psychiatry
- Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
- (2014) S G Fillman et al. Translational Psychiatry
- Biomarkers in Schizophrenia: A Brief Conceptual Consideration
- (2013) Cynthia S. Weickert et al. DISEASE MARKERS
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1 and with increased CSF KYNA level and reduced KMO expression
- (2013) C Lavebratt et al. MOLECULAR PSYCHIATRY
- Serum testosterone levels are related to cognitive function in men with schizophrenia
- (2013) L. Moore et al. PSYCHONEUROENDOCRINOLOGY
- Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia
- (2013) F.M. Notarangelo et al. SCHIZOPHRENIA RESEARCH
- Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
- (2012) G. C. Prendergast et al. CURRENT MEDICINAL CHEMISTRY
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
- (2012) S G Fillman et al. MOLECULAR PSYCHIATRY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- Anti-inflammatory treatment in schizophrenia
- (2012) Norbert Müller et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
- (2011) Patricia A Zunszain et al. NEUROPSYCHOPHARMACOLOGY
- Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
- (2010) Cynthia Shannon Weickert et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
- (2010) K. R. Linderholm et al. SCHIZOPHRENIA BULLETIN
- Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
- (2009) J K Yao et al. MOLECULAR PSYCHIATRY
- CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
- (2009) C L Raison et al. MOLECULAR PSYCHIATRY
- Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies
- (2009) A. Fornito et al. SCHIZOPHRENIA RESEARCH
- Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
- (2008) S Barry et al. JOURNAL OF PSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started